LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Conference to Deal with MS Application in Clinical Labs

By LabMedica International staff writers
Posted on 12 Oct 2010
The American Association for Clinical Chemistry (AACC) has announced that a one-day conference, Practical Applications of Mass Spectrometry in the Clinical Laboratory, will be held on November 15, 2010, at Johns Hopkins Medical Institution (Baltimore, MD, USA).

The program has been created to explain some of the issues that are arising as mass spectrometry (MS) evolves into a routine laboratory application. The conference faculty will address the expanding use of MS in the clinical laboratory: its advantages and disadvantages; the basics of MS method evaluation; and laboratory considerations in MS applications for therapeutic drug monitoring (TDM), vitamin D, thyroid, catecholamine, and steroid analyses, and toxicology.

In the clinical laboratory the focus of MS for some decades has mainly been on the screening of newborns for metabolic disorders. As a result, clinical laboratory staff and pathologists have had only limited access to this method. However, MS is becoming increasingly accepted for routine assays in the clinical laboratory.

AACC is a professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations.

Related Links:
American Association for Clinical Chemistry
Johns Hopkins Medical Institution


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more